Cision PR Newswire

Global Dental Implants and Final Abutment Market Faces Price Sensitivity Challenges Amid Surging Demand for Aesthetic Innovation

News provided by

Nov 25, 2024, 11:30 AM ET

VANCOUVER, BC, Nov. 25, 2024 /PRNewswire/ - The global dental implants and final abutment market is undergoing a transformative shift, driven by an increasing demand for improved aesthetics and long-lasting solutions in restorative dentistry. However, the market's growth is tempered by price sensitivity among patients and practitioners, particularly in emerging economies, where affordability remains a significant barrier. Meanwhile, advancements in the global dental bone graft substitutes market—essential for enhancing implant success rates—are creating synergistic opportunities, further reinforcing the role of innovative materials and techniques in shaping the future of dental care. By 2030, the global dental implants and final abutment market is expected to reach $9.2 billion with the global dental bone graft substitute reaching $2.6 billion.

Price Sensitivity as a Key Market Limiter

Price sensitivity remains a significant challenge in the dental implants market, with premium products facing increasing competition from lower-priced alternatives. Even within the premium segment, moderate price rivalry is evident. In Europe, cost-conscious patients and dental professionals are driving demand for discounted and value implant products, which are expected to capture over half of the market value by the end of the forecast period. Similarly, in the Asia-Pacific (APAC) region, value-based implants and final abutments are gaining traction as cost-effective alternatives, with China being an exception. In China, the government's volume-based purchasing (VBP) initiative is expected to increase the market share of premium implants as manufacturers lower prices to remain competitive. Meanwhile, in Latin America (LATAM), low GDP and economic constraints have led to widespread cost sensitivity, fuelling a rise in off-label and imitation products marketed as bioequivalent to premium implants from leading companies like the Straumann Group.

Growing Demand for Improved Aesthetics

Dental implants are increasingly favoured for single-tooth replacements, which represent the fastest-growing application segment due to their superior aesthetics compared to conventional options like bridges. This trend is particularly prominent in the U.S., Europe, and APAC, where shorter, immediate-loading procedures are becoming more popular. In Latin America, the growing emphasis on aesthetic dentistry is driving awareness and acceptance of implants. Local dentists are actively promoting implantology as one of the most profitable and desirable treatments, supported by the increasing popularity of training programs and high public awareness of dental aesthetics.

Interplay Between Dental Bone Graft Substitutes and Implants

The dental bone graft substitute market is intrinsically linked to the dental implant market, with bone grafting being a critical step for approximately 40% of implant procedures. This connection stems from the necessity of bone grafts in cases where patients lack sufficient jawbone density to support a dental implant, underscoring their foundational role in ensuring implant success. As the adoption of dental implants continues to rise, driven by a growing emphasis on aesthetics and functional restoration, the demand for advanced bone graft substitutes is expected to increase proportionately. Innovations in grafting materials, such as synthetic and bioengineered solutions, are not only improving procedural outcomes but also expanding accessibility to a broader patient base. This dynamic interplay between the two markets fosters a mutually reinforcing cycle of growth, where advancements in one sector catalyze progress in the other, paving the way for a more integrated and robust dental care ecosystem over the forecast period.

Competitive Analysis

Straumann Group leads the dental implant and final abutment market, leveraging its strong brand reputation and history of delivering top-tier dental implants. Dominating the premium implant segment, Straumann's success is fueled by its comprehensive suite of implant-associated products. Its subsidiary, Neodent, solidified leadership in the value implant segment, significantly bolstering Straumann's overall market position. The company's focus on mergers and acquisitions further enhances its profile, ensuring continued market leadership.

Envista ranked as the second-largest competitor, with products spanning all segments of the dental implant and abutment market, though without a clear leadership position in any single segment. Approximately 40% of Envista's revenue stems from implant sales, supported by trends like an aging population, dental digitization, and growing DSOs. After separating from Danaher in 2019, Envista became a publicly traded company, using IPO proceeds to acquire its core brands, including Nobel Biocare and Implant Direct. As an independent company, Envista is positioned to accelerate product growth and improve margins.

Dentsply Sirona was the third-leading competitor, excelling in the surgical guide and treatment planning software segments while remaining a key player in dental implants and abutments. Its value brand, MIS Implants, captures demand from cost-conscious consumers, complementing a highly diversified portfolio. Launching around 30 new products annually, Dentsply Sirona continues to leverage its extensive product range to drive growth across all market segments.

In Summary

In conclusion, the symbiotic relationship between the dental implants and bone graft substitutes markets underscores the evolving landscape of restorative dentistry, where innovation and accessibility drive mutual growth. As the adoption of dental implants accelerates, fueled by patient demand for superior aesthetics and functionality, the need for advanced bone graft substitutes continues to expand, creating new opportunities across the global market. Key players such as Straumann Group, Envista, and Dentsply Sirona are at the forefront of this evolution, leveraging their extensive product portfolios and research capabilities to maintain a competitive edge. These industry leaders are not only addressing challenges like price sensitivity with cost-efficient solutions but also setting benchmarks for quality and innovation in both markets. As competition intensifies, strategic investments in R&D, partnerships, and targeted geographic expansion will remain critical for sustaining market leadership and capturing the growing demand in this dynamic and interconnected field.

To learn more about the dental implants and final abutment and the dental bone graft substitutes markets, see all our market report offerings through the links below:

Dental Implants and Final Abutment Research:

Dental Implant and Final Abutment Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite

Dental Implants Market Size, Share & Trends Analysis | India | 2024-2030 | MedSuite

Dental Implants Market Size, Share & Trends Analysis | China | 2024-2030 | MedSuite

Dental Implants Market Size, Share & Trends Analysis | Australia | 2024-2030 | MedSuite

Dental Implants Market Size, Share & Trends Analysis | South Korea | 2024-2030 | MedSuite

Dental Implants Market Size, Share & Trends Analysis | Japan | 2024-2030 | MedSuite

Dental Implants and Final Abutments Market Size, Share & Trends Analysis | Europe | 2023-2029 | MedSuite

Dental Implants Market Size, Share & COVID-19 Impact Analysis | Latin America | 2023-2029 | MedSuite

Dental Implants Market Size, Share & COVID19 Impact Analysis | United States | 2023-2029 | MedSuite

Dental Bone Graft Substitutes Research:

Dental Bone Graft Substitute and Other Biomaterials Market Size, Share, and Trends Analysis | Global | 2024-2030 | MedSuite